Editorial: Equity in type 1 diabetes technology and beyond: where are we in 2022?
- Resource Type
- Editorial & Opinion
- Authors
- Burckhardt MA; Pediatric Endocrinology and Diabetology, University Children's Hospital, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland.; Addala A; Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, United States.; Stanford Diabetes Research Center, Stanford University, Stanford, CA, United States.; de Bock M; Department of Paediatrics, University of Otago, Christchurch, New Zealand.
- Source
- Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
- Subject
- Language
- English
- ISSN
- 1664-2392
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.